South Korea's Hyundai Motor Co. sold a total of 4,917 hydrogen fuel cell electric vehicles, accounting for 74 percent of the global hydrogen car market, to top global sales in the first nine months of the year.
Hyundai attributes its robust performance to the rising demand for the Nexo hydrogen model.
Hyundai began selling the Nexo locally in March 2018 to take the leadership position in hydrogen mobility technology.
This year, Hyundai eyes selling 10,100 Nexos in Korea, mainly to companies and public organizations, more than doubling the 4,194 units it sold last year.
From January to November, Hyundai sold 5,453 units of Nexo locally, achieving 54 percent of its annual target. It also exported 6,318 Nexos during the same period.
The second placer was Toyota Motors Corp., with a share of 11.5 percent, or 767 vehicles, while Honda Motor Co. came in third with a 2.8 percent share, or 187 units.
Hyundai also plans to develop more hydrogen commercial vehicles, such as buses and trucks, to fortify its leading position in hydrogen vehicles.
The company is set to build a production facility capable of manufacturing 50,000 hydrogen-powered vehicles annually by 2030 while selling 200,000 hydrogen fuel cell systems a year in global markets.


Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
Australia Targets Meta, Google, and TikTok With New News Payment Tax Proposal
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Google Secures Pentagon AI Deal for Classified Projects
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 



